Couldn't load this record
The USPTO API returned an error (HTTP 429) — please try again shortly.
Patent Application
Utility
App. No. 18/967,488
· Confirmation No. 7707
BUPROPION AS A MODULATOR OF DRUG ACTIVITY
Inventor:
Herriot Tabuteau
Applicant:
ANTECIP BIOVENTURES II LLC
Docketed New Case - Ready for Examination
View Publication ↗
No downloadable documents found — record may not be publicly available.
Inventors
Herriot Tabuteau
New York, NY
Attorneys & Agents of Record
Classification
USPC
514/289
A61K31/485
A61P25/24
A61K31/137
Prosecution
- Examiner
- CENTRAL, DOCKET
- Art Unit
- OPAP
- Customer No.
- 27189
- Docket No.
- 134061-00000665
- Confirmation No.
- 7707
Publication
- Pub. No.
- US20250205223A1
- Pub. Date
- 2025-06-26
Parent
is a Continuation of
→
App. 17/730,814
Filed 2022-04-27
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 63/188,716
Filed 2021-05-14
· Provisional Application Expired
Child
is a Continuation of
→
App. 19/258,712
Filed 2025-07-02
· Notice of Allowance Mailed -- Application Received in Office of Publications
Child
is a Continuation of
→
App. 19/684,927
Filed 2026-05-21
· Special New
from
TABUTEAU, HERRIOT
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2025-02-10
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/967,488
- Filed
- 2024-12-03
- Pub. No.
- US20250205223A1
- Examiner
- CENTRAL, DOCKET
- Art Unit
- OPAP
External Links